Ownership Summary
Translational Development Acquisition Corp. (NASDAQ:TDACU) has 5 institutional investors with active 13F positions as of March 2026.
- These investors held 4.7% of outstanding shares in March 2026, down from 4.7% in December 2025.
- They maintained total shares held in Translational Development Acquisition by 0.0% from last quarter, and the number of investors in TDACU decreased 79.17% annually.
- Of these 5 funds, 0 grew their exposure to Translational Development Acquisition, 0 cut back, and 5 maintained positions.
- In total, institutional investors held 807.43K shares in Translational Development Acquisition as of March 2026, with no net change quarter on quarter, and down 3.96Mn shares year over year.
- Calamos Advisors LLC holds the largest position in TDACU at 375.0K shares as of March 31, 2026, or 2.17% of shares outstanding.
- Per Business Quant, the top 5 investors in TDACU for the quarter ending March 2026 include Calamos Advisors LLC (375.0K), D. E. Shaw & Co., Inc. (350.0K), Yakira Capital Management, Inc. (60.0K), FLOW TRADERS U.S. LLC (14.09K), UBS Group AG (8.34K).